Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia
scientific article published on 26 September 2006
Author/s
author: Larry J Schaaf, John C. Byrd, Nyla A Heerema, James T Dalton, Kristie A Blum, Michael R Grever, Mitch A Phelps, Gerard Lozanski, Mollie Moran, Thomas Lin Pedersen, Michelle Brooker-McEldowney, Sarah Broering, Donn C Young
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.